{"slug":"thymosin-alpha-1-ppis","verification":{"valid":true,"entries":4,"head":"4116e66c752c16799d08009364f5286004a706bef847f72b622b97edd9ee84db"},"count":4,"sources":[{"id":"s0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11377960/","title":"Proton pump inhibitor alters Th17/Treg balance and induces gut dysbiosis","quote":"Treatment with PPIs alters gut microbiota composition and reduces the production of reactive oxygen (ROS) and proinflammatory IL-1β, IL-6, and TNF-α cytokines.","summary":"Preclinical study on PPI immune and microbiota effects.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:57:58.291Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"eeab9565566e25e8dceb41d0070fe7e9997864b6c645acedea61f05310e0a5fe"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7747025/","title":"Thymosin alpha 1: A comprehensive review of the literature","quote":"Clinical studies show that thymosin alpha 1 has been utilized in patients with different malignancies, reducing the toxicity of chemotherapy, and improving the ...","summary":"Review of human studies on TA1 immune effects.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:57:58.291Z","link_status":"ok","quote_status":"unverified","prev":"eeab9565566e25e8dceb41d0070fe7e9997864b6c645acedea61f05310e0a5fe","hash":"e0992c04da4874d7beef8d484f83b92a5522bac0459e243897412e6d3a9142cb"},{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38308608/","title":"Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1","quote":"Based on substantial evidence from clinical trials, Tα1 emerges as a well-tolerated and effective immune modulator.","summary":"2024 review of >11,000 human subjects.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:57:58.291Z","link_status":"ok","quote_status":"verified","prev":"e0992c04da4874d7beef8d484f83b92a5522bac0459e243897412e6d3a9142cb","hash":"4cc5b7f3678fae15c24fe0c19572900ba3eba4c7687502c87f3d7293f753e586"},{"id":"s13","type":"pubmed","url":"https://www.bmj.com/content/388/bmj-2024-082583","title":"The efficacy and safety of thymosin α1 for sepsis (TESTS)","quote":"This trial found no clear evidence to suggest that thymosin α1 decreases 28 day all cause mortality in adults with sepsis.","summary":"2025 RCT results.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:57:58.291Z","link_status":"http_403","quote_status":"unverified","prev":"4cc5b7f3678fae15c24fe0c19572900ba3eba4c7687502c87f3d7293f753e586","hash":"4116e66c752c16799d08009364f5286004a706bef847f72b622b97edd9ee84db"}]}